PharmiNews

The Directory of Pharma Companies and News

XBiotech

XBiotech logo
XBiotech is a fully integrated global biosciences company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies based on its True Human(TM) proprietary technology. XBiotech currently is advancing a robust pipeline of antibody therapies to redefine the standards of care in oncology, inflammatory conditions and infectious diseases. Headquartered in Austin, Texas, XBiotech also is leading the development of innovative biotech manufacturing technologies designed to more rapidly, cost-effectively and flexibly produce new therapies urgently needed by patients worldwide.
Category: Biotech
Category: Biotech

XBiotech News

DateNews
2017-06-09XBiotech Announces Discontinuation of Phase III Study for Colorectal Cancer Based on Second Interim Analysis
2017-06-01XBiotech Presents Phase III Findings for its Antibody Therapy for Colorectal Cancer at the 2017 ASCO Meeting
2017-05-30Dr. Razelle Kurzrock to Present Novel Biomarker Findings from XBiotech Phase III Colorectal Cancer Study Data at the 19t...
2017-04-28XBiotech to Provide First Quarter 2017 Business Update
2017-04-20XBiotech Announces Outcome of EMA’s Oral Explanation Meeting
2017-04-10XBiotech Announces Additions To Its Scientific Advisory Board
2017-04-03XBiotech Announces Top-Line Results for 514G3 Antibody Therapy in Serious Staphylococcus aureus Infections
2017-03-27XBiotech Announces On-Time Submission to the EMA
2017-03-23XBiotech Announces Addition of Dr. Dirk Arnold to its Scientific Advisory Board
2017-03-09XBiotech to Provide Fourth Quarter and Full Year 2016 Business Update
2017-03-03XBiotech Announces Registered Direct Offering of Common Shares
2017-02-22XBiotech Completes Dosing of Subjects in PK Study Being Conducted in Connection with European Marketing Application
2017-02-21XBiotech Reports Affirmative Interim Analysis of Global Phase 3 Colorectal Cancer Study
2017-01-17XBiotech Phase 3 Data for Colorectal Cancer Therapy is Published in The Lancet Oncology
2016-12-07XBiotech Completes Enrollment in Global Phase III Study using Xilonix Monotherapy to Treat Advanced Colorectal Cancer
2016-12-06XBiotech Completes Enrollment in Global Phase I/II Study for its True Human™ Antibody Treatment for Serious Staphylococc...
2016-11-17XBiotech Announces Research Collaboration with Renowned Gastroenterologist
2016-11-10XBiotech to Provide Third Quarter 2016 Business Update on November 15
2016-10-12XBiotech Announces Successful Completion of EMA GMP Inspection
2016-10-11XBiotech Announces Dismissal of Class Action Lawsuit in Texas
2016-08-22XBiotech Announces Grand Opening Date for New Commercial Manufacturing Facility
2016-08-10XBiotech to Provide Second Quarter 2016 Business Update on August 16
2016-07-22XBiotech Provides Update on Xilonix™ Phase III Programs in US and EU
2016-07-02XBiotech Presents Pivotal Phase III Data Showing Xilonix(TM) Demonstrated Significant Clinical Response in Advanced Colo...
2016-07-02XBiotech Presents Pivotal Phase III Data Showing Xilonix™ Demonstrated Significant Clinical Response in Advanced Colorec...
2016-06-28XBiotech Signs Agreement With Megapharm To Market Xilonix(TM) In Israel
2016-06-28XBiotech Signs Agreement With Megapharm To Market Xilonix™ In Israel
2016-06-08XBiotech Appoints Trey Benson as New Commercial Head to Lead Strategic Commercial Development for the Company's Extensiv...
2016-06-08XBiotech Appoints Trey Benson as New Commercial Head to Lead Strategic Commercial Development for the Company’s Extensiv...
2016-05-24XBiotech to Present Positive Preliminary Survival Data on Xilonix(TM) at the 18th European Society of Medical Oncology's...
2016-05-24XBiotech to Present Positive Preliminary Survival Data on Xilonix™ at the 18th European Society of Medical Oncology’s Wo...
2016-05-18XBiotech Provides First Quarter 2016 Corporate and Clinical Update
2016-05-16XBiotech Names Industry Veteran Dawn McCollough to Head Clinical Operations
2016-05-11XBiotech to Provide First Quarter 2016 Business Update on May 18
2016-05-03XBiotech Appoints Amgen Veteran Scott Whitehurst as Chief Financial Officer
2016-04-19XBiotech to Present Pivotal Phase 3 Data on Xilonix(TM) at European Society of Medical Oncology's World Congress on Gast...
2016-04-19XBiotech to Present Pivotal Phase 3 Data on Xilonix™ at European Society of Medical Oncology’s World Congress on Gastroi...
2016-04-04European Medicines Agency Grants Accelerated Assessment of Marketing Authorization Application for Xilonix(TM), XBiotech...
2016-04-04European Medicines Agency Grants Accelerated Assessment of Marketing Authorization Application for Xilonix™, XBiotech’s ...
2016-03-28XBiotech Advances to Phase II Portion of Clinical Study of Novel True Human™ Therapeutic Antibody for Treating Serious I...
2016-03-23XBiotech Announces European Medicines Agency (EMA) Validates Marketing Authorization Application (MAA) for Xilonix™ in t...
2016-03-22XBiotech to Provide Fourth Quarter and Full Year 2015 Business update
2016-03-09XBiotech Enrolls Final Patient in Phase I Portion of Clinical Study of Novel True Human™ Therapeutic Antibody for Treati...
2016-03-08XBiotech Announces Submission of Marketing Authorization Application (MAA) for Candidate Colorectal Cancer Therapy to Eu...
2016-03-04European Medicines Agency Grants Eligibility for Submission of XBiotech’s Marketing Authorization Application (MAA)
2016-03-02XBiotech to Deliver Presentation on Novel Study Design and Phase III Results From European Study on Xilonix(TM) During M...
2016-03-02XBiotech to Deliver Presentation on Novel Study Design and Phase III Results From European Study on Xilonix™ During Meet...
2016-02-18XBiotech to Present at 4th Annual Sachs Cancer BioPartnering & Investment Forum
2016-02-11XBiotech Engages in Research for Heart Attack Antibody Therapy
2016-01-21XBiotech to Attend and Present at the ASCO 2016 Gastrointestinal Cancers Symposium
2016-01-08XBiotech Reports Additional Positive Data From Phase III European Trial of Xilonix™ in Advanced Colorectal Cancer
2016-01-07XBiotech Advances to Final Dosing Cohort in Phase 1/2 Clinical Study of Novel True Human™ Therapeutic Antibody for Treat...
2016-01-07XBiotech to Host Overview of Strategy and Findings for Its European Phase III Trial for Treatment of Colorectal Cancer W...
2016-01-06XBiotech Added to NASDAQ Biotechnology Index
2015-12-11XBiotech Announces Agreement With the NCIC Clinical Trials Group to Collaborate on Phase II Study in Non-Small Cell Lung...
2015-12-07XBiotech Announces Positive Results in European Phase III Study for Its Breakthrough Therapy for Colorectal Cancer
2015-11-23XBiotech Provides Update on Phase III Oncology Study in Europe
2015-11-20XBiotech Added to the MSCI US Small Cap 1750 and the MSCI Investable Market 2500 Indexes
2015-11-12XBiotech Provides Third Quarter 2015 Corporate and Clinical Update
2015-11-11XBiotech Identifies Positive Donors for Anti-Clostridium difficile Therapeutic Antibody Only Two Weeks After Initial Scr...
2015-11-09XBiotech Announces Positive Results for Its Anti-Ebola Therapeutic Candidates Following Evaluation by USAMRIID
2015-11-05XBiotech to Provide Third Quarter Business Update
2015-10-26XBiotech Initiates Program to Develop Antibody Against Clostridium Difficile
2015-10-21XBiotech Presents Findings at Investigator Conference for Staphylococcus Aureus Program
2015-10-19XBiotech Strengthens Intellectual Property Portfolio for Its True Human(TM) Antibody Technology
2015-10-02XBiotech Announces Publication of Clinical Results Supporting the Potential of Its True Human(TM) Antibody as a Cardiova...
2015-10-01XBiotech Receives FDA Fast Track Designation for Its Novel True Human(TM) Therapeutic Antibody for Treating Serious Infe...
2015-09-01XBiotech Advances Phase 1/2 Clinical Study of Novel True Human(TM) Therapeutic Antibody for Treating Serious Infections ...
2015-08-17XBiotech Completes Enrollment for Xilonix(TM) Phase III Registration Study in Europe
2015-08-07XBiotech Announces Expansion of Global Phase 3 Registration Study in Europe using Xilonix(TM) for Treatment of Metastati...
2015-07-28XBiotech Provides Second Quarter 2015 Corporate and Clinical Update
2015-07-15XBiotech to Provide Second Quarter Business Update
2015-07-07XBiotech Announces Publication of Clinical Results Supporting Its True Human(TM) Antibody Therapy for Type 2 Diabetes Me...
2015-07-06XBiotech Treats First Patient in Phase 1/2 Clinical Study of Novel True Human(TM) Therapeutic Antibody for Treating Seri...
2015-07-01XBiotech Conducts Investigators Meeting to Update the Status of Its Phase III Registration Study Underway in Europe
2015-06-24XBiotech Added to Russell 2000 Index
2015-06-15CORRECTING and REPLACING -- XBiotech Announces Publication of Phase 2 Clinical Results for Its True Human(TM) Antibody M...
2015-06-15XBiotech Announces Publication of Phase 2 Clinical Results for Its True Human(TM) Antibody MABp1 for Treating Acne Vulga...
2015-06-08XBiotech Appoints Kelly R. Thornburg as Senior Vice President of Operations
2015-05-28XBiotech Launching Phase 1/2 Clinical Study of Novel True Human(TM) Therapeutic Antibody for Treating Serious Infections...
2015-05-26XBiotech Successfully Clones First Anti-Ebola Therapeutic Antibody Product Candidate
2015-05-18XBiotech Secures Approval From Data Safety Monitoring Board to Continue Phase 3 Registration Study in Europe for Its Nov...
Brought to you by PharmiWeb.com - Latest Jobs in Pharma
Brought to you by www.pharmiweb.com - Latest Jobs in Pharma.